Daniela Z.
- Country
- Denmark
- Department
- Onkologisk afdeling
Research Overview
- Phase III Randomized Study of Lurbinectedin Alone or with Irinotecan Versus Topotecan or Irinotecan in Relapsed Small Cell Lung Cancer Patients
- Evaluation of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin in Locally Advanced Colon Cancer: A Comparative Study with Standard Treatment
- Phase 3 Randomized Study of Nivolumab + Relatlimab FDC with Chemotherapy vs. Pembrolizumab with Chemotherapy in Stage IV/Recurrent NSCLC with PD-L1 ≥1%
Data & Insights
Has run more than one trial at 48 of 225 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in advanced therapeutic approaches for small cell lung cancer (SCLC), with particular focus on treatment strategies for patients who have experienced relapse after initial platinum-based chemotherapy.
- Novel therapeutic agents in SCLC
- Treatment of relapsed lung cancer
- Combination therapy approaches
The investigator evaluates various treatment modalities including single-agent and combination therapies for advanced lung cancer cases.
Gastrointestinal Oncology
The investigator focuses on innovative treatment approaches for locally advanced colon cancer, exploring the potential benefits of different therapeutic sequences in treatment protocols.
- Neoadjuvant chemotherapy strategies
- Advanced colon cancer management
- Disease-free survival optimization
Their research examines the effectiveness of pre-surgical therapeutic interventions in improving patient outcomes.
Treatment Innovation
The investigator explores comparative therapeutic approaches across different cancer types, focusing on optimizing treatment sequences and evaluating various drug combinations.
- Alternative treatment strategies
- Therapy sequence optimization
- Clinical outcome assessment
Their work encompasses the evaluation of both standard and experimental treatment protocols in oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.